STRONTIUM RANELATE REDUCES THE RISK OF VERTEBRAL FRACTURES IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN WITHOUT PREVALENT VERTEBRAL FRACTURE

被引：0

作者：

Reginster, J. ^{[1
]}

Rizzoli, R. ^{[2
]}

Balogh, A. ^{[3
]}

Badurski, J. ^{[4
]}

Spector, T. ^{[5
]}

Tulassay, Z. ^{[6
]}

Felsenberg, D. ^{[7
]}

Cannata, J. B. ^{[8
]}

Phenekos, C. ^{[9
]}

Ortolani, S. ^{[10
]}

Meunier, P. J. ^{[11
]}

机构：

[1] Univ Liege, Dept Epidemiol & Publ Hlth, Liege, Belgium

[2] Univ Hosp Geneva, Div Bone Dis, Geneva, Switzerland

[3] Univ Debrecen, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary

[4] Polish Fdn Osteoporosis, Ctr Osteoporosis & Osteo Articular Dis, Bialystok, Poland

[5] St Thomas Hosp, Dept Rheumatol, London, England

[6] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary

[7] Charite, D-13353 Berlin, Germany

[8] Univ Oviedo, Hosp Cent Asturias, Unidad Invest Metab Oseo & Min, E-33080 Oviedo, Spain

[9] Red Cross Hosp, Dept Endocrinol, Athens, Greece

[10] Ist Auxol Italiano, Ctr Metab Bone Dis, Milan, Italy

[11] Hop Edouard Herriot, Dept Rheumatol & Bone Dis, Lyon, France

来源：

CALCIFIED TISSUE INTERNATIONAL | 2004年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S83 / S83

页数：1

共 50 条

[41] Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
P. J. Meunier
C. Roux
S. Ortolani
M. Diaz-Curiel
J. Compston
P. Marquis
C. Cormier
G. Isaia
J. Badurski
J. D. Wark
J. Collette
J. Y. Reginster
Osteoporosis International, 2009, 20 : 1663 - 1673
[42] To assess the quality of life in postmenopausal osteoporotic women with and without vertebral fractures
Olcenler, S
Cerrahoglu, L
OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S94 - S94
[43] Pain and quality of life in postmenopausal osteoporotic women without vertebral fractures
Garip, Yesim
Eser, Filiz
Sayin, Selim
Bodur, Hatice
Cavusoglu, Mehtap
EUROPEAN JOURNAL OF THERAPEUTICS, 2015, 21 (02): : 99 - 103
[44] Strontium ranelate reduces the risk of hip fracture in women with postmenopausal osteoporosis
Reginster, JY
Sawicki, A
Devogelaer, JP
Padrino, JM
Kaufma, JM
Doyle, DV
Fardellone, P
Graham, J
Felsenberg, D
Tulassay, Z
Soren-Sen, OH
Luisetto, G
Rizzoli, R
Blotman, F
Phenekos, C
Meunier, PJ
OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S14 - S14
[45] EFFECTIVENESS OF DIFFERENT MODALITIES FOR OSTEOPOROTIC POSTMENOPAUSAL WOMEN WITHOUT VERTEBRAL FRACTURE
Patru, S.
Bighea, A.
Popescu, R.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 47 - 47
[46] Strontium ranelate: A new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in postmenopausal women with osteoporosis
Reginster, JY
Hoszowski, K
Varela, AR
Balogh, A
Clements, M
Fiore, C
Cormier, C
Schmidt, WE
Jensen, JB
Prince, R
Raeman, F
Rizzoli, R
Meunier, PJ
BONE, 2003, 32 (05) : S94 - S94
[47] Risedronate Reduces the Risk of First Vertebral Fracture in Osteoporotic Women
R. P. Heaney
T. M. Zizic
I. Fogelman
W. P. Olszynski
P. Geusens
C. Kasibhatla
N. Alsayed
G. Isaia
M. W. Davie
C. H. Chesnut III
Osteoporosis International, 2002, 13 : 501 - 505
[48] Risedronate reduces the risk of first vertebral fracture in osteoporotic women
Heaney, RP
Zizic, TM
Fogelman, I
Olszynski, WP
Geusens, P
Kasibhatla, C
Alsayed, N
Isaia, G
Davie, MW
Chesnut, CH
OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 501 - 505
[49] Correction to: Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study
E. Kanterewicz
E. Puigoriol
J.R. Rodríguez Cros
P. Peris
Osteoporosis International, 2019, 30 : 1901 - 1902
[50] Strontium ranelate: New efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women
Meunier, PJ
Lorenc, RS
Smith, IG
Roces-Varela, A
Passariello, R
Bonidan, O
Kruse, HP
Raeman, F
Prince, R
De Chatel, R
Charles, P
Fechtenbaum, J
Roux, C
Reginster, JY
OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S34 - S34

← 1 2 3 4 5 →